Ensuring Ethical Postprogression Therapy for Patients in Randomized Trial Control Arms

J Clin Oncol. 2023 Aug 20;41(24):3984-3987. doi: 10.1200/JCO.22.02675. Epub 2023 Jun 21.

Authors

Edward R Scheffer Cliff^{1

2}, Aaron S Kesselheim^{1

2}, William B Feldman^{1

2}

Affiliations

¹ Program on Regulation, Therapeutics and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, MA.
² Harvard Medical School, Boston, MA.

PMID: 37343194
DOI: 10.1200/JCO.22.02675

No abstract available

Publication types

Randomized Controlled Trial
Research Support, Non-U.S. Gov't

MeSH terms

Clinical Protocols
Disease-Free Survival*
Humans